🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,760 results for “Pharm” Clear

  1. Fremanezumab

    Teva Pharma GmbH

    Migraine

    approved small molecule active

    9 trials

  2. Fremanezumab Prefilled Syringe [Ajovy]

    Teva Pharma GmbH

    Migraine Disorders

    approved small molecule terminated

    1 trial

  3. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial

  4. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Lennox-Gastaut Syndrome

    approved small molecule terminated

    1 trial

  5. Glatiramer Acetate

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    approved small molecule terminated

    5 trials

  6. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial

  7. ICD Ablation plus VT-ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    1 trial

  8. ILUVIEN

    ANI PHARMACEUTICALS INC

    Chronic Diabetic Macular Edema

    approved small molecule completed

    1 trial

  9. ILUVIEN 0.19 MG

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema (DME)

    approved small molecule completed

    1 trial

  10. INCLISIRAN SODIUM, BEMPEDOIC ACID, ATORVASTATIN, ROSUVASTATIN, EZETIMIBE

    Novartis Pharmaceuticals

    Hypercholesterolemia

    approved small molecule active

    1 trial

  11. IPTACOPAN HYDROCHLORIDE, IPTACOPAN

    Novartis Pharmaceuticals

    C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis

    approved small molecule active

    1 trial

  12. IV Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Chronic Pelvic Pain

    approved small molecule active

    1 trial

  13. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  14. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Arthroscopic Knee Surgery

    approved small molecule completed

    1 trial

  15. IXCHIQ

    Ars Pharmaceuticals Irl Limited

    Chikungunya Virus Infection

    approved mab active

    1 trial

  16. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Ductus Arteriosus, Patent

    approved small molecule terminated

    1 trial

  17. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  18. Iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Schizophrenia

    approved small molecule active

    5 trials

  19. Iluvien 0.19 MG Drug Implant

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema

    approved small molecule active

    1 trial

  20. Implantable Cardiac Defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    2 trials

  21. Implantable Cardiac Monitor

    Rhythm Pharmaceuticals Netherlands B.V.

    Chagas Disease

    approved other terminated

    1 trial

  22. Implantable Defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Disease

    approved other completed

    1 trial

  23. Implantable cardioverter defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Acute Myocardial Infarction

    approved other completed

    1 trial

  24. Indacaterol

    Novartis Pharmaceuticals

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources